These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28884714)

  • 1. [Therapeutic monitoring and prediction of the efficacy of neurotrophic treatment in patients with amnestic type of mild cognitive impairment].
    Gavrilova SI; Volpina OM; Kolykhalov IV; Fedorova YB; Selezneva ND; Ponomareva EV; Koroev DO; Kamynina AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):27-38. PubMed ID: 28884714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis of cognitive deficit progression in aged patients with mild cognitive impairment under prolonged therapy (a three year observation)].
    Gavrilova SI; Kolykhalov IV; Fedorova IaB; Kalyn IaB; Selezneva ND; Samorodov AV; Miasoedov SN; Boksha IS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(3):45-53. PubMed ID: 23612410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-inflammatory effects of neurotrophic therapy (a pilot study)].
    Malashenkova IK; Krynskiy SA; Hailov NA; Ogurtsov DP; Selezneva ND; Fedorova YB; Ponomareva EV; Kolyhalov IV; Gavrilova SI; Didkovsky NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):39-44. PubMed ID: 29927402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of effective treatment of amnestic mild cognitive impairement with cereton by testing of lipids markers].
    Alesenko AV; Gavrilova SI; Gutner UA; Lebedeva AO; Shupik MA; Kolykhalov IV; Ponomareva EV; Selezneva ND; Fedorova YB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):21-27. PubMed ID: 28745666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.
    Buschert VC; Friese U; Teipel SJ; Schneider P; Merensky W; Rujescu D; Möller HJ; Hampel H; Buerger K
    J Alzheimers Dis; 2011; 25(4):679-94. PubMed ID: 21483095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The therapeutic potential of cerebrolysin in the preventive therapy of Alzheimer's disease].
    Gavrilova SI; Fedorova IaB; Kolykhalov IV; Odinak MM; Emelin AIu; Kashin AV; Selezneva ND; Kalyn IaB; Roshchina IF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):24-8. PubMed ID: 18833104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Episodic memory and delayed recall are significantly more impaired in younger patients with deficit schizophrenia than in elderly patients with amnestic mild cognitive impairment.
    Kanchanatawan B; Tangwongchai S; Supasitthumrong T; Sriswasdi S; Maes M
    PLoS One; 2018; 13(5):e0197004. PubMed ID: 29763451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of progression of cognitive decline in the first-degree relatives of patients with Alzheimer's disease].
    Selezneva ND; Roshchina IF; Korovaitseva GI; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):30-36. PubMed ID: 30499493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
    Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine improves semantic memory in patients with amnestic mild cognitive impairment: A single-photon emission computed tomography study.
    Ilhan Algin D; Dagli Atalay S; Ozkan S; Ozbabalik Adapinar D; Ak Sivrioz I
    J Int Med Res; 2017 Dec; 45(6):2053-2064. PubMed ID: 28661262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese.
    Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M
    Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Delayed effects of cerebrolysin in the prevention of cognitive impairment progression in the first degree relatives of patients with Alzheimer's disease: the role of the ApoE genotype].
    Selezneva ND; Gavrilova SI; Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10. Vyp. 2):31-38. PubMed ID: 33205928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.
    Müller S; Saur R; Greve B; Melms A; Hautzinger M; Fallgatter AJ; Leyhe T
    Mult Scler; 2013 May; 19(6):799-805. PubMed ID: 23166118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
    Choi HJ; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Lee JM; Woo JI; Lee DY
    Am J Geriatr Psychiatry; 2016 Feb; 24(2):144-53. PubMed ID: 26238231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semantic clustering and sleep in patients with amnestic mild cognitive impairment or with vascular cognitive impairment-no dementia.
    Sun Q; Luo L; Ren H; Wei C; Xing M; Cheng Y; Zhang N
    Int Psychogeriatr; 2016 Sep; 28(9):1493-502. PubMed ID: 27169617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric predictors of conversion to dementia both in patients with amnestic mild cognitive impairment and those with subcortical vascular MCI.
    Kim SH; Kang HS; Kim HJ; Ryu HJ; Kim My; Seo SW; Na DL; Han SH
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1264-70. PubMed ID: 23290121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms.
    Xiao S; Xue H; Li G; Yuan C; Li X; Chen C; Wu HZ; Mitchell P; Zhang M
    Aust N Z J Psychiatry; 2012 Feb; 46(2):153-60. PubMed ID: 22311531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.